Immedica Pharma’s Acquisition of Pegzilarginase Assets from Aeglea

Leila Ahmed
Tagged:

Davis Polk & Wardwell advised Immedica Pharma AB on the transaction.Immedica Pharma AB announced its acquisition from Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) of all assets related to…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here